ID   KKU-213L5
AC   CVCL_C6MZ
SY   KKU213L5; KKU-213 Lung metastatic variant 5
DR   Wikidata; Q116049620
RX   PubMed=27461717;
CC   Population: Southeast Asian; Thai.
CC   Characteristics: Highly metastatic. Established from the parent cell line passaged in a NOD/scid/Jak3 mice (NOJ mice).
CC   Doubling time: 20.3 hours (PubMed=27461717).
CC   Sequence variation: Mutation; HGNC; 6407; KRAS; Simple; p.Gly13Cys (c.37G>T); ClinVar=VCV000045123; Zygosity=Unspecified (from parent cell line).
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
DI   NCIt; C35417; Intrahepatic cholangiocarcinoma
DI   NCIt; C27769; Opisthorchis viverrini-related cholangiocarcinoma
DI   ORDO; Orphanet_70567; Cholangiocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_M261 ! KKU-213A
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 15-12-22; Last updated: 29-06-23; Version: 3
//
RX   PubMed=27461717; DOI=10.3892/or.2016.4974;
RA   Uthaisar K., Vaeteewoottacharn K., Seubwai W., Talabnin C.,
RA   Sawanyawisuth K., Obchoei S., Kraiklang R., Okada S., Wongkham S.;
RT   "Establishment and characterization of a novel human
RT   cholangiocarcinoma cell line with high metastatic activity.";
RL   Oncol. Rep. 36:1435-1446(2016).
//